U.S. In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Instruments, Services), By Technology (Immunoassay, Molecular Diagnostics), By Application, By End-use, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Methodology and Scope
                    1.1 Market Segmentation and Scope
                        1.1.1 Estimates And Forecast Timeline
                    1.2 Research Methodology
                    1.3 Information procurement
                        1.3.1 Purchased Database:
                        1.3.2 GVR’s Internal Database
                        1.3.3 Secondary Sources
                        1.3.4 Primary Research
                    1.4 Information or Data Analysis
                        1.4.1 Data Analysis Models
                    1.5 Market Formulation & Validation
                    1.6 Model Details
                        1.6.1 Commodity Flow Analysis (Model 1)
                            1.6.1.1 Approach 1: Commodity Flow Approach
                    1.7 Research Assumptions
                    1.8 List of Secondary Sources
                    1.9 List of Abbreviations
                    1.10 Objectives
                        1.10.1 Objective 1
                        1.10.2 Objective 2
                        1.10.3 Objective 3
                        1.10.4 Objective 4
Chapter 2 Executive Summary
                    2.1 Market Outlook
Chapter 3 U.S. IVD Market Variables, Trends, & Scope
                    3.1 IVD Market Lineage Outlook
                        3.1.1 Parent Market Outlook
                    3.2 Penetration and Growth Prospect Mapping
                    3.3 Regulatory Framework
                    3.4 Market Driver Analysis
                        3.4.1 Growing Geriatric Population
                        3.4.2 Technological Advancements
                        3.4.3 Increasing Demand For Poc Facilities
                        3.4.4 Growing Prevalence Of Target Diseases Such As Genetic, Cardiovascular, And Neurological Diseases, And Hospital-Acquired Infections
                        3.4.5 Outbreak Of COVID-19
                    3.5 Market Restraint Analysis
                        3.5.1 Higher Cost Of Devices
                        3.5.2 Stringent Regulatory Policies
                    3.6 Value Chain Analysis
                        3.6.1 Value Chain Analysis/Route To Market
                    3.7 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
                    3.8 Porter’s Five Forces Analysis
                    3.9 Major Deals and Strategic Alliances Analysis
                        3.9.1 launch of New products
                        3.9.2 Mergers and acquisitions
                        3.9.3 Expansion
                        3.9.4 Partnerships
                        3.9.5 Marketing & promotions
                    3.10 Mergers And Deals
Chapter 4 U.S. IVD Market-Segment Analysis, by Product, 2017 - 2030 (USD Million)
                    4.1 U.S. In Vitro Diagnostic Market: Products Movement Analysis
                    4.2 Instruments
                        4.2.1 Instruments Market Estimates And Forecast, 2017 - 2030 (USD Million) Volume (Number Of Instruments)
                    4.3 Reagents
                        4.3.1 Reagents Market Estimates And Forecast, 2017 - 2030 (USD Million) Volume (Number Of Tests)
                    4.4 Services
                        4.4.1 Services Market Estimates And Forecast, 2017 - 2030 (USD Million)
Chapter 5 U.S. IVD Market-Segment Analysis, by Technology, 2017 - 2030 (USD Million)
                    5.1 In Vitro Diagnostics Market: Technology Movement Analysis
                    5.2 Immunoassay
                        5.2.1 Immunoassay Market Estimates And Forecast, 2017 - 2030 (USD Million)
                        5.2.2 Instruments
                            5.2.2.1 Instruments market for immunoassay estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                        5.2.3 Reagents
                            5.2.3.1 Reagents market for immunoassay estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                        5.2.4 Services
                            5.2.4.1 Services market for immunoassay estimates and forecast, 2017 - 2030 (USD Million)
                    5.3 Hematology
                        5.3.1 Hematology Market Estimates And Forecast, 2017 - 2030 (USD Million)
                        5.3.2 Instruments
                            5.3.2.1 Instruments market for hematology estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                        5.3.3 Reagents
                            5.3.3.1 Reagents market for hematology estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                        5.3.4 Services
                            5.3.4.1 Services market for hematology estimates and forecast, 2017 - 2030 (USD Million)
                    5.4 Clinical Chemistry
                        5.4.1 Clinical Chemistry Market Estimates And Forecast, 2017 - 2030 (USD Million)
                        5.4.2 Instruments
                            5.4.2.1 Instruments market for clinical chemistry estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                        5.4.3 Reagents
                            5.4.3.1 Reagents market for clinical chemistry estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                        5.4.4 Services
                            5.4.4.1 Services market for clinical chemistry estimates and forecast, 2017 - 2030 (USD Million)
                    5.5 Molecular Diagnostics
                        5.5.1 Moecular Diagnostics Market Estimates And Forecast, 2017 - 2030 (USD Million)
                        5.5.2 Instruments
                            5.5.2.1 Instruments market for molecular diagnostics estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                        5.5.3 Reagents
                            5.5.3.1 Reagents market for molecular diagnostics estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                        5.5.4 Services
                            5.5.4.1 Services market for molecular diagnostics estimates and forecast, 2017 - 2030 (USD Million)
                    5.6 Coagulation
                        5.6.1 Coagulation Market Estimates And Forecast, 2017 - 2030 (USD Million)
                        5.6.2 Instruments
                            5.6.2.1 Instruments market for coagulation estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                        5.6.3 Reagents
                            5.6.3.1 Reagents market for coagulation estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                        5.6.4 Services
                            5.6.4.1 Services market for coagulation estimates and forecast, 2017 - 2030 (USD Million)
                    5.7 Microbiology
                        5.7.1 Microbiology Market Estimates And Forecast, 2017 - 2030 (USD Million)
                        5.7.2 Instruments
                            5.7.2.1 Instruments market for microbiology estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                        5.7.3 Reagents
                            5.7.3.1 Reagents market for microbiology estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                        5.7.4 Services
                            5.7.4.1 Services market for microbiology estimates and forecast, 2017 - 2030 (USD Million)
                    5.8 Others
                        5.8.1 Others Market Estimates And Forecast, 2017 - 2030 (USD Million)
                        5.8.2 Instruments
                            5.8.2.1 Instruments market estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                        5.8.3 Reagents
                            5.8.3.1 Reagents market estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                        5.8.4 Services
                            5.8.4.1 Services market estimates and forecast, 2017 - 2030 (USD Million)
Chapter 6 U.S. IVD Market: Segment Analysis, by End Use, 2017 - 2030 (USD Million)
                    6.1 In Vitro Diagnostic Market: End-use Movement Analysis
                    6.2 Hospitals
                        6.2.1 Hospitals Market Estimates And Forecast, 2017 - 2030 (USD Million)
                        6.2.2 Hospitals Market, By TechnologY
                            6.2.2.1 Immunoassay
                            6.2.2.2 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
                                6.2.2.2.1 Instruments market estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                                6.2.2.2.2 Reagents market estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                                6.2.2.2.3 Services market estimates and forecast, 2017 - 2030 (USD Million)
                            6.2.2.3 Hematology
                            6.2.2.4 Hematology market estimates and forecast, 2017 - 2030 (USD Million)
                                6.2.2.4.1 Instruments market estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                                6.2.2.4.2 Reagents market estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                                6.2.2.4.3 Services market estimates and forecast, 2017 - 2030 (USD Million)
                            6.2.2.5 Clinical Chemistry
                            6.2.2.6 Clinical chemistry market estimates and forecast, 2017 - 2030 (USD Million)
                                6.2.2.6.1 Instruments market estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                                6.2.2.6.2 Reagents market estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                                6.2.2.6.3 Services market estimates and forecast, 2017 - 2030 (USD Million)
                            6.2.2.7 Molecular Diagnostics
                            6.2.2.8 Molecular diagnostics market estimates and forecast, 2017 - 2030 (USD Million)
                                6.2.2.8.1 Instruments market estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                                6.2.2.8.2 Reagents market estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                                6.2.2.8.3 Services market estimates and forecast, 2017 - 2030 (USD Million)
                            6.2.2.9 Coagulation
                            6.2.2.10 Coagulation market estimates and forecast, 2017 - 2030 (USD Million)
                                6.2.2.10.1 Instruments market estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                                6.2.2.10.2 Reagents market estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                                6.2.2.10.3 Services market estimates and forecast, 2017 - 2030 (USD Million)
                            6.2.2.11 Microbiology
                            6.2.2.12 Microbiology market estimates and forecast, 2017 - 2030 (USD Million)
                                6.2.2.12.1 Instruments market estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                                6.2.2.12.2 Reagents market estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                                6.2.2.12.3 Services market estimates and forecast, 2017 - 2030 (USD Million)
                            6.2.2.13 Others
                            6.2.2.14 Others market estimates and forecast, 2017 - 2030 (USD Million)
                                6.2.2.14.1 Instruments market estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                                6.2.2.14.2 Reagents market estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                                6.2.2.14.3 Services market estimates and forecast, 2017 - 2030 (USD Million)
                    6.3 Laboratory
                        6.3.1 Laboratory Market Estimates And Forecast, 2017 - 2030 (USD Million)
                        6.3.2 Laboratory Market, By Technology
                            6.3.2.1 Immunoassay
                            6.3.2.2 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
                                6.3.2.2.1 Instruments market estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                                6.3.2.2.2 Reagents market estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                                6.3.2.2.3 Services market estimates and forecast, 2017 - 2030 (USD Million)
                            6.3.2.3 Hematology
                            6.3.2.4 Hematology market estimates and forecast, 2017 - 2030 (USD Million)
                                6.3.2.4.1 Instruments market estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                                6.3.2.4.2 Reagents market estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                                6.3.2.4.3 Services market estimates and forecast, 2017 - 2030 (USD Million)
                            6.3.2.5 Clinical Chemistry
                            6.3.2.6 Clinical chemistry market estimates and forecast, 2017 - 2030 (USD Million)
                                6.3.2.6.1 Instruments market estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                                6.3.2.6.2 Reagents market estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                                6.3.2.6.3 Services market estimates and forecast, 2017 - 2030 (USD Million)
                            6.3.2.7 Molecular Diagnostics
                            6.3.2.8 Molecular diagnostics market estimates and forecast, 2017 - 2030 (USD Million)
                                6.3.2.8.1 Instruments market estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                                6.3.2.8.2 Reagents market estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                                6.3.2.8.3 Services market estimates and forecast, 2017 - 2030 (USD Million)
                            6.3.2.9 Coagulation
                            6.3.2.10 Coagulation market estimates and forecast, 2017 - 2030 (USD Million)
                                6.3.2.10.1 Instruments market estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                                6.3.2.10.2 Reagents market estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                                6.3.2.10.3 Services market estimates and forecast, 2017 - 2030 (USD Million)
                            6.3.2.11 Microbiology
                            6.3.2.12 Microbiology market estimates and forecast, 2017 - 2030 (USD Million)
                                6.3.2.12.1 Instruments market estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                                6.3.2.12.2 Reagents market estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                                6.3.2.12.3 Services market estimates and forecast, 2017 - 2030 (USD Million)
                            6.3.2.13 Others
                            6.3.2.14 Others market estimates and forecast, 2017 - 2030 (USD Million)
                                6.3.2.14.1 Instruments market estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                                6.3.2.14.2 Reagents market estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                                6.3.2.14.3 Services market estimates and forecast, 2017 - 2030 (USD Million)
                    6.4 Home Care
                        6.4.1 Home Care Market Estimates And Forecast, 2017 - 2030 (USD Million)
                        6.4.2 Home Care Market, By Technology
                            6.4.2.1 Immunoassay
                            6.4.2.2 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
                                6.4.2.2.1 Instruments market estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                                6.4.2.2.2 Reagents market estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                                6.4.2.2.3 Services market estimates and forecast, 2017 - 2030 (USD Million)
                            6.4.2.3 Hematology
                            6.4.2.4 Hematology market estimates and forecast, 2017 - 2030 (USD Million)
                                6.4.2.4.1 Instruments market estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                                6.4.2.4.2 Reagents market estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                                6.4.2.4.3 Services market estimates and forecast, 2017 - 2030 (USD Million)
                            6.4.2.5 Clinical Chemistry
                            6.4.2.6 Clinical chemistry market estimates and forecast, 2017 - 2030 (USD Million)
                                6.4.2.6.1 Instruments market estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                                6.4.2.6.2 Reagents market estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                                6.4.2.6.3 Services market estimates and forecast, 2017 - 2030 (USD Million)
                            6.4.2.7 Molecular Diagnostics
                            6.4.2.8 Molecular diagnostics market estimates and forecast, 2017 - 2030 (USD Million)
                                6.4.2.8.1 Instruments market estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                                6.4.2.8.2 Reagents market estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                                6.4.2.8.3 Services market estimates and forecast, 2017 - 2030 (USD Million)
                            6.4.2.9 Coagulation
                            6.4.2.10 Coagulation market estimates and forecast, 2017 - 2030 (USD Million)
                                6.4.2.10.1 Instruments market estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                                6.4.2.10.2 Reagents market estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                                6.4.2.10.3 Services market estimates and forecast, 2017 - 2030 (USD Million)
                            6.4.2.11 Microbiology
                            6.4.2.12 Microbiology market estimates and forecast, 2017 - 2030 (USD Million)
                                6.4.2.12.1 Instruments market estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                                6.4.2.12.2 Reagents market estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                                6.4.2.12.3 Services market estimates and forecast, 2017 - 2030 (USD Million)
                            6.4.2.13 Others
                            6.4.2.14 Others market estimates and forecast, 2017 - 2030 (USD Million)
                                6.4.2.14.1 Instruments market estimates and forecast, 2017 - 2030 (USD Million) volume (number of instruments)
                                6.4.2.14.2 Reagents market estimates and forecast, 2017 - 2030 (USD Million) volume (number of tests)
                                6.4.2.14.3 Services market estimates and forecast, 2017 - 2030 (USD Million)
                    6.5 Others
                        6.5.1 Other Market Estimates And Forecast, 2017 - 2030 (USD Million)
Chapter 7 U.S. IVD Market: Segment Analysis, by Application, 2017 - 2030 (USD Million)
                    7.1 U.S. In Vitro Diagnostics Market: Application Movement Analysis
                    7.2 Infectious Diseases
                        7.2.1 Infectious Diseases Market Estimates And Forecast, 2017 - 2030 (USD Million)
                            7.2.1.1 Upper respiratory
                                7.2.1.1.1 Upper respiratory market estimates and forecast, 2017 - 2030 (USD Million)
                            7.2.1.2 Gastrointestinal panel testing
                                7.2.1.2.1 Gastrointestinal panel testing market estimates and forecast, 2017 - 2030 (USD Million)
                            7.2.1.3 Methicillin-resistant Staphylococcus Aureus (MRSA)
                                7.2.1.3.1 MRSA market estimates and forecast, 2017 - 2030 (USD Million)
                            7.2.1.4 Clostridium difficile
                                7.2.1.4.1 Clostridium difficile market estimates and forecast, 2017 - 2030 (USD Million)
                            7.2.1.5 Vancomycin-Resistant Enterococci (VRE)
                                7.2.1.5.1 VRE market estimates and forecast, 2017 - 2030 (USD Million)
                            7.2.1.6 Carbapenem-resistant bacteria
                                7.2.1.6.1 Carbapenem-resistant bacteria market estimates and forecast, 2017 - 2030 (USD Million)
                            7.2.1.7 Flu
                                7.2.1.7.1 Flu market estimates and forecast, 2017 - 2030 (USD Million)
                            7.2.1.8 Respiratory Syncytial Virus (RSV)
                                7.2.1.8.1 RSV market estimates and forecast, 2017 - 2030 (USD Million)
                            7.2.1.9 Candida
                                7.2.1.9.1 Candida market estimates and forecast, 2017 - 2030 (USD Million)
                            7.2.1.10 Tuberculosis (TB) and drug-resistant TB
                                7.2.1.10.1 TB and drug-resistant TB market estimates and forecast, 2017 - 2030 (USD Million)
                            7.2.1.11 Meningitis
                                7.2.1.11.1 Meningitis market estimates and forecast, 2017 - 2030 (USD Million)
                            7.2.1.12 Chlamydia
                                7.2.1.12.1 Chlamydia market estimates and forecast, 2017 - 2030 (USD Million)
                            7.2.1.13 Gonorrhoea
                                7.2.1.13.1 Gonorrhoea market estimates and forecast, 2017 - 2030 (USD Million)
                            7.2.1.14 HIV
                                7.2.1.14.1 HIV market estimates and forecast, 2017 - 2030 (USD Million)
                            7.2.1.15 Hepatitis C
                                7.2.1.15.1 Hepatitis C market estimates and forecast, 2017 - 2030 (USD Million)
                            7.2.1.16 Hepatitis B
                                7.2.1.16.1 Hepatitis B market estimates and forecast, 2017 - 2030 (USD Million)
                            7.2.1.17 Other infectious disease market
                                7.2.1.17.1 Other infectious disease market estimates and forecast, 2017 - 2030 (USD Million)
                    7.3 Diabetes
                        7.3.1 Diabetes Market Estimates And Forecast, 2017 - 2030 (USD Million)
                    7.4 Oncology
                        7.4.1 Oncology Market Estimates And Forecast, 2017 - 2030 (USD Million)
                    7.5 Cardiology
                        7.5.1 Cardiology Market Estimates And Forecast, 2017 - 2030 (USD Million)
                    7.6 Nephrology
                        7.6.1 Nephrology Market Estimates And Forecast, 2017 - 2030 (USD Million)
                    7.7 Autoimmune Diseases
                        7.7.1 Autoimmune Diseases Market Estimates And Forecast, 2017 - 2030 (USD Million)
                    7.8 Drug Testing
                        7.8.1 Drug Testing Market Estimates And Forecast, 2017 - 2030 (USD Million)
                    7.9 Hematologic Diseases
                        7.9.1 Hematologic Diseases Market Estimates And Forecast, 2017 - 2030 (USD Million)
                    7.10 Others
                        7.10.1 Others Market Estimates And Forecast, 2017 - 2030 (USD Million)
Chapter 8 U.S. IVD Market: Segment Analysis, by Region, 2017 - 2030 (USD Million)
                    8.1 Regional Analysis - The U.S. IVD Market
                        8.1.1 Trends In U.S. IVD Market
                        8.1.2 U.S. IVD Market Estimates And Forecast, 2017 - 2030 (USD Million)
Chapter 9 Competitive Analysis
                    9.1 Recent Developments and Impact Analysis, by Key Market Participants
                        9.1.1 ANSOFF MATRIX
                        9.1.2 Company/Competition Categorization (Key Innovators, Market Leaders, Expansion)
                        9.1.3 Innovators
                    9.2 Vendor Landscape
                        9.2.1 List Of Key Distributors And Channel Partners
                        9.2.2 U.S. IVD Market: Key Company Market Share Analysis, 2021
                        9.2.3 Competitive Dashboard Analysis
                        9.2.4 Strategic Framework
                    9.3 Private Companies
                        9.3.1 List Of Key Emerging Companies /Technology Disruptors/Innovators
                        9.3.2 Regional Network Map
                    9.4 Company Profiles
                        9.4.1 ABBOTT
                            9.4.1.1 Company overview
                            9.4.1.2 Alere, Inc.
                            9.4.1.3 Financial performance
                            9.4.1.4 Product benchmarking
                            9.4.1.5 Strategic initiatives
                        9.4.2 BIOMÉRIEUX SA
                            9.4.2.1 Company overview
                            9.4.2.2 Financial performance
                            9.4.2.3 Product benchmarking
                            9.4.2.4 Strategic initiatives
                        9.4.3 BIO-RAD LABORATORIES, INC.
                            9.4.3.1 Company overview
                            9.4.3.2 Financial performance
                            9.4.3.3 Product benchmarking
                            9.4.3.4 Strategic initiatives
                        9.4.4 BECTON, DICKINSON AND COMPANY
                            9.4.4.1 Company overview
                            9.4.4.2 Financial performance
                            9.4.4.3 Product benchmarking
                            9.4.4.4 Strategic initiatives
                        9.4.5 SIEMENS HEALTHINEERS AG
                            9.4.5.1 Company overview
                            9.4.5.2 Financial performance
                            9.4.5.3 Product benchmarking
                            9.4.5.4 Strategic initiatives
                        9.4.6 QIAGEN
                            9.4.6.1 Company overview
                            9.4.6.2 Financial performance
                            9.4.6.3 Product benchmarking
                            9.4.6.4 Strategic initiatives
                        9.4.7 QUIDEL CORPORATION
                            9.4.7.1 Company Overview
                            9.4.7.2 Financial Performance
                            9.4.7.3 Product benchmarking
                            9.4.7.4 Strategic initiatives
                        9.4.8 F. HOFFMANN-LA ROCHE LTD.
                            9.4.8.1 Company overview
                            9.4.8.2 Financial performance
                            9.4.8.3 Product benchmarking
                            9.4.8.4 Strategic initiatives
                        9.4.9 SYSMEX CORPORATION
                            9.4.9.1 Company overview
                            9.4.9.2 Financial performance
                            9.4.9.3 Product benchmarking
                            9.4.9.4 Strategic initiatives
                        9.4.10 QUEST DIAGNOSTICS
                            9.4.10.1 Company overview
                            9.4.10.2 Financial Performance
                            9.4.10.3 Product benchmarking
                            9.4.10.4 Strategic initiatives
                        9.4.11 AGILENT TECHNOLOGIES, INC.
                            9.4.11.1 Company overview
                            9.4.11.2 Financial performance
                            9.4.11.3 Product benchmarking
                            9.4.11.4 Strategic initiatives
                        9.4.12 DANAHER CORPORATION
                            9.4.12.1 Company overview
                            9.4.12.2 Cepheid
                            9.4.12.3 Beckman Coulter
                            9.4.12.4 Leica Biosystems
                            9.4.12.5 Financial performance
                            9.4.12.6 Product benchmarking
                            9.4.12.7 Strategic initiatives
                            9.4.12.8 Strategic initiatives - Beckman Coulter, Inc.
                            9.4.12.9 Strategic initiatives - Leica Biosystems
Chapter 10 U.S. IVD Market: Competitive Landscape By Application, H. Pylori Market
                    10.1 Company Profiles
                        10.1.1 MERIDIAN BIOSCIENCE, INC.
                            10.1.1.1 Company overview
                            10.1.1.2 Financial performance
                            10.1.1.3 Product benchmarking
                            10.1.1.4 Strategic initiatives
                        10.1.2 ABBOTT
                            10.1.2.1 Company overview
                            10.1.2.2 Alere, Inc.
                            10.1.2.3 Financial performance
                            10.1.2.4 Product benchmarking
                        10.1.3 THERMO FISHER SCIENTIFIC INC.
                            10.1.3.1 Company overview
                            10.1.3.2 Financial performance
                            10.1.3.3 Product benchmarking
                        10.1.4 EPITOPE DIAGNOSTICS, INC
                            10.1.4.1 Product benchmarking
                        10.1.5 BIO-RAD LABORATORIES, INC.
                            10.1.5.1 Company overview
                            10.1.5.2 Financial performance
                            10.1.5.3 Product benchmarking
                        10.1.6 SEKISUI DIAGNOSTICS, LLC
                            10.1.6.1 Company overview
                            10.1.6.2 Financial performance
                            10.1.6.3 Product benchmarking
                        10.1.7 DIASORIN MOLECULAR LLC
                            10.1.7.1 Company overview
                            10.1.7.2 Financial performance
                            10.1.7.3 Product benchmarking
                            10.1.7.4 Strategic initiatives
                        10.1.8 QUEST DIAGNOSTICS
                            10.1.8.1 Company overview
                            10.1.8.2 Financial Performance
                            10.1.8.3 Product benchmarking
                        10.1.9 BIOHIT OYJ
                            10.1.9.1 Financial performance
                            10.1.9.2 Product benchmarking
                        10.1.10 QUIDEL CORPORATION
                            10.1.10.1 Company Overview
                            10.1.10.2 Financial Performance
                            10.1.10.3 Product benchmarking
                    10.2 Public Companies Analysis
                        10.2.1 Company Market Position Analysis
                        10.2.2 Competitive Dashboard Analysis
                            10.2.2.1 Market Differentiators
                    10.3 Private Companies Analysis
                    10.4 Key company market share analysis, 2021
Chapter 11 U.S. IVD Market: Competitive Landscape By Application, C. difficile Market
                    11.1 Company Profiles
                        11.1.1 MERIDIAN BIOSCIENCE, INC.
                            11.1.1.1 Company overview
                            11.1.1.2 Financial performance
                            11.1.1.3 Product benchmarking
                        11.1.2 ALTONA DIAGNOSTICS GMBH
                            11.1.2.1 Company overview
                            11.1.2.2 Product benchmarking
                        11.1.3 THERMO FISHER SCIENTIFIC, INC.
                            11.1.3.1 Company overview
                            11.1.3.2 Financial performance
                            11.1.3.3 Product benchmarking
                        11.1.4 TRINITY BIOTECH PLC
                            11.1.4.1 Financial performance
                            11.1.4.2 Product benchmarking
                        11.1.5 ABNOVA CORPORATION
                            11.1.5.1 Financial performance
                            11.1.5.2 Product benchmarking
                        11.1.6 BD (BECTON, DICKINSON AND COMPANY)
                            11.1.6.1 Company overview
                            11.1.6.2 Company overview
                            11.1.6.3 Financial performance
                            11.1.6.4 Product benchmarking
                        11.1.7 TECHLAB INC.
                            11.1.7.1 Product benchmarking
                        11.1.8 F. HOFFMANN-LA ROCHE LTD
                            11.1.8.1 Company overview
                            11.1.8.2 Financial performance
                            11.1.8.3 Product benchmarking
                        11.1.9 ANTYLIA SCIENTIFIC
                            11.1.9.1 ZeptoMetrix
                            11.1.9.2 Product benchmarking
                        11.1.10 QUIDEL CORPORATION
                            11.1.10.1 Company Overview
                            11.1.10.2 Financial Performance
                            11.1.10.3 Product benchmarking
                            11.1.10.4 Strategic initiatives
                    11.2 Public Companies Analysis
                        11.2.1 Company Market Position Analysis
                        11.2.2 Competitive Dashboard Analysis
                            11.2.2.1 Market Differentiators
                    11.3 Private Companies Analysis
                    11.4 Key company market share analysis, 2021
Chapter 12 U.S. IVD Market: Competitive Landscape By Application, Shiga Toxin (E. coli) Market
                    12.1 Company Profiles and Recent Developments & Impact Analysis, By Key Market Participants
                        12.1.1 MERIDIAN BIOSCIENCE, INC.
                            12.1.1.1 Company overview
                            12.1.1.2 Financial performance
                            12.1.1.3 Product benchmarking
                        12.1.2 ABBOTT
                            12.1.2.1 Company overview
                            12.1.2.2 Alere, Inc.
                            12.1.2.3 Financial performance
                            12.1.2.4 Product benchmarking
                        12.1.3 THERMO FISHER SCIENTIFIC, INC.
                            12.1.3.1 Company overview
                            12.1.3.2 Financial performance
                            12.1.3.3 Product benchmarking
                            12.1.3.4 Strategic initiatives
                        12.1.4 BIOMÉRIEUX SA
                            12.1.4.1 Company overview
                            12.1.4.2 Financial performance
                            12.1.4.3 Product benchmarking
                        12.1.5 BIO-RAD LABORATORIES, INC.
                            12.1.5.1 Company overview
                            12.1.5.2 Financial performance
                            12.1.5.3 Product benchmarking
                            12.1.5.4 Strategic initiatives
                        12.1.6 ALTONA DIAGNOSTICS GMBH
                            12.1.6.1 Company overview
                            12.1.6.2 Product benchmarking
                        12.1.7 DIASORIN MOLECULAR LLC
                            12.1.7.1 Company overview
                            12.1.7.2 Financial performance
                            12.1.7.3 Product benchmarking
                        12.1.8 F. HOFFMANN-LA ROCHE LTD.
                            12.1.8.1 Company overview
                            12.1.8.2 Financial performance
                            12.1.8.3 Product benchmarking
                        12.1.9 QIAGEN
                            12.1.9.1 Company overview
                            12.1.9.2 Financial performance
                            12.1.9.3 Product benchmarking
                        12.1.10 QUIDEL CORPORATION
                            12.1.10.1 Company Overview
                            12.1.10.2 Financial Performance
                            12.1.10.3 Product benchmarking
                    12.2 Public Companies Analysis
                        12.2.1 Company Market Position Analysis
                        12.2.2 Competitive Dashboard Analysis
                            12.2.2.1 Market Differentiators
                    12.3 Private Companies Analysis
                    12.4 Key company market share analysis, 2021
Chapter 13 U.S. IVD Market: Competitive Landscape By Application, Strep A and Strep B Market
                    13.1 Company Profiles
                        13.1.1 MERIDIAN BIOSCIENCE, INC.
                            13.1.1.1 Company overview
                            13.1.1.2 Financial performance
                            13.1.1.3 Product benchmarking
                        13.1.2 ABBOTT
                            13.1.2.1 Company overview
                            13.1.2.2 Alere, Inc.
                            13.1.2.3 Financial performance
                            13.1.2.4 Product benchmarking
                            13.1.2.5 Strategic initiatives
                        13.1.3 THERMO FISHER SCIENTIFIC INC.
                            13.1.3.1 Company overview
                            13.1.3.2 Financial performance
                            13.1.3.3 Product benchmarking
                            13.1.3.4 Strategic initiatives
                        13.1.4 BIOMÉRIEUX SA
                            13.1.4.1 Company overview
                            13.1.4.2 Financial performance
                            13.1.4.3 Product benchmarking
                        13.1.5 BIO-RAD LABORATORIES, INC.
                            13.1.5.1 Company overview
                            13.1.5.2 Financial performance
                            13.1.5.3 Product benchmarking
                        13.1.6 SSI DIAGNOSTICA
                            13.1.6.1 Company overview
                            13.1.6.2 CTK biotech INC.
                            13.1.6.3 Product benchmarking
                        13.1.7 DIASORIN MOLECULAR LLC
                            13.1.7.1 Company overview
                            13.1.7.2 Financial performance
                            13.1.7.3 Product benchmarking
                            13.1.7.4 Strategic initiatives
                        13.1.8 F. HOFFMANN-LA ROCHE LTD.
                            13.1.8.1 Company overview
                            13.1.8.2 Financial performance
                            13.1.8.3 Product benchmarking
                        13.1.9 QIAGEN
                            13.1.9.1 Company overview
                            13.1.9.2 Financial performance
                            13.1.9.3 Product benchmarking
                        13.1.10 QUIDEL CORPORATION
                            13.1.10.1 Company Overview
                            13.1.10.2 Financial Performance
                            13.1.10.3 Product benchmarking
                            13.1.10.4 Strategic initiatives
                    13.2 Public Companies Analysis
                        13.2.1 Company Market Position Analysis
                        13.2.2 Competitive Dashboard Analysis
                            13.2.2.1 Market Differentiators
                    13.3 Private Companies Analysis
                    13.4 Key company market share analysis, 2021
Chapter 14 U.S. IVD Market: Competitive Landscape By Application, Blood/hematology lead detection Market
                    14.1 Company Profiles
                        14.1.1 MERIDIAN BIOSCIENCE, INC.
                            14.1.1.1 Magellan Diagnostics
                            14.1.1.2 Financial performance
                            14.1.1.3 Product benchmarking
                            14.1.1.4 Strategic initiatives
                        14.1.2 MERCK KGAA
                            14.1.2.1 Financial performance
                            14.1.2.2 Product benchmarking
                        14.1.3 BD (Becton, Dickinson And Company)
                            14.1.3.1 Company overview
                            14.1.3.2 Financial performance
                            14.1.3.3 Product benchmarking
                    14.2 List of Lead Testing Laboratory
                    14.3 Public Companies Analysis
                        14.3.1 Company Market Position Analysis
                        14.3.2 Competitive Dashboard Analysis
                            14.3.2.1 Market Differentiators
                    14.4 Private Companies Analysis
Chapter 15 U.S. IVD Market: Competitive Landscape By Application, Influenza Market
                    15.1 Company Profiles
                        15.1.1 ABBOTT
                            15.1.1.1 Company overview
                            15.1.1.2 Alere, Inc.
                            15.1.1.3 Financial performance
                            15.1.1.4 Product benchmarking
                            15.1.1.5 Strategic initiatives
                        15.1.2 BD (BECTON, DICKINSON AND COMPANY)
                            15.1.2.1 Company overview
                            15.1.2.2 Financial performance
                            15.1.2.3 Product benchmarking
                            15.1.2.4 Strategic initiatives
                        15.1.3 QUIDEL CORPORATION
                            15.1.3.1 Company Overview
                            15.1.3.2 Financial Performance
                            15.1.3.3 Product Benchmarking
                            15.1.3.4 Strategic Initiatives
                        15.1.4 THERMO FISHER SCIENTIFIC, INC.
                            15.1.4.1 Company overview
                            15.1.4.2 Financial performance
                            15.1.4.3 Product benchmarking
                            15.1.4.4 Strategic initiatives
                        15.1.5 LUMINEX CORPORATION
                            15.1.5.1 Company overview
                            15.1.5.2 Financial performance
                            15.1.5.3 Product benchmarking
                            15.1.5.4 Strategic initiatives
                        15.1.6 CEPHEID (DANAHER CORPORATION)
                            15.1.6.1 Company Overview
                            15.1.6.2 Financial Performance
                            15.1.6.3 Product Benchmarking
                            15.1.6.4 Strategic Initiatives
                        15.1.7 MERIDIAN BIOSCIENCE, INC.
                            15.1.7.1 Company overview
                            15.1.7.2 Financial performance
                            15.1.7.3 Product benchmarking
                            15.1.7.4 Strategic initiatives
                        15.1.8 BIOMÉRIEUX SA
                            15.1.8.1 Company overview
                            15.1.8.2 Financial performance
                            15.1.8.3 Product benchmarking
                            15.1.8.4 Strategic initiatives
                        15.1.9 SEKISUI DIAGNOSTICS
                            15.1.9.1 Company overview
                            15.1.9.2 Financial performance
                            15.1.9.3 Product benchmarking
                            15.1.9.4 Strategic initiatives
                        15.1.10 SIEMENS HEALTHINEERS
                            15.1.10.1 Company overview
                            15.1.10.2 Financial performance
                            15.1.10.3 Product benchmarking
                    15.2 Recent Developments and Impact Analysis, by Key Market Participants
                        15.2.1 Major Deals And Strategic Alliances Analysis
                            15.2.1.1 New Product Launches
                            15.2.1.2 Mergers and Acquisitions
                            15.2.1.3 Partnerships and Strategic Collaboration
                            15.2.1.4 Conferences and Campaigns
                    15.3 Public Companies Analysis
                        15.3.1 Company Market Position Analysis
                        15.3.2 Competitive Dashboard Analysis
                            15.3.2.1 Market Differentiators
                    15.4 Private Companies Analysis
                    15.5 Key company market share analysis, 2021
Chapter 16 U.S. IVD Market: Competitive Landscape By Application, STDs Market
                    16.1 Company Profiles
                        16.1.1 ABBOTT
                            16.1.1.1 Company overview
                            16.1.1.2 Alere, Inc.
                            16.1.1.3 Financial performance
                            16.1.1.4 Product benchmarking
                            16.1.1.5 Strategic initiatives
                        16.1.2 BD (BECTON, DICKINSON AND COMPANY)
                            16.1.2.1 Company overview
                            16.1.2.2 Financial performance
                            16.1.2.3 Product benchmarking
                            16.1.2.4 Strategic initiatives
                        16.1.3 SIEMENS HEALTHINEERS
                            16.1.3.1 Company overview
                            16.1.3.2 Financial performance
                            16.1.3.3 Product benchmarking
                            16.1.3.4 Strategic initiatives
                        16.1.4 BIOMÉRIEUX SA
                            16.1.4.1 Company overview
                            16.1.4.2 Financial performance
                            16.1.4.3 Product benchmarking
                        16.1.5 BIO-RAD LABORATORIES, INC.
                            16.1.5.1 Company overview
                            16.1.5.2 Financial performance
                            16.1.5.3 Product benchmarking
                            16.1.5.4 Strategic initiatives
                        16.1.6 DANAHER CORPORATION
                            16.1.6.1 Company overview
                            16.1.6.2 Cepheid
                            16.1.6.3 Beckman Coulter
                            16.1.6.4 Leica Biosystems
                            16.1.6.5 Financial performance
                            16.1.6.6 Product benchmarking
                        16.1.7 DIASORIN MOLECULAR LLC
                            16.1.7.1 Company overview
                            16.1.7.2 Financial performance
                            16.1.7.3 Product benchmarking
                            16.1.7.4 Strategic initiatives
                        16.1.8 HOLOGIC, INC.
                            16.1.8.1 Company overview
                            16.1.8.2 Financial performance
                            16.1.8.3 Product benchmarking
                            16.1.8.4 Strategic initiatives
                        16.1.9 F. HOFFMANN-LA ROCHE LTD
                            16.1.9.1 Company overview
                            16.1.9.2 Financial performance
                            16.1.9.3 Product benchmarking
                            16.1.9.4 Strategic initiatives
                        16.1.10 QIAGEN
                            16.1.10.1 Company overview
                            16.1.10.2 Financial performance
                            16.1.10.3 Product benchmarking
                            16.1.10.4 Strategic initiatives
                    16.2 Recent Developments and Impact Analysis, by Key Market Participants
                        16.2.1 Major Deals And Strategic Alliances Analysis
                            16.2.1.1 New product launches
                            16.2.1.2 Mergers and acquisitions
                            16.2.1.3 Expansion
                            16.2.1.4 Partnerships and collaborations
                    16.3 Public Companies Analysis
                        16.3.1 Company Market Position Analysis
                        16.3.2 Competitive Dashboard Analysis
                            16.3.2.1 Market Differentiators
                    16.4 Private Companies Analysis
                    16.5 Key company market share analysis, 2021

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Regulatory framework
Table 4 Current oversight of diagnostic tests
Table 5 EUA IVD tests for COVID-19 in March and April 2020 (Early Entrants)
Table 6 List of FDA approved immunoassays during early stage of pandemic
Table 7 List of key distributors
Table 8 List of key emerging companies/technology disruptors/innovators
Table 9 U.S. in vitro diagnostics market, by product, 2017 - 2030 (USD Million) (Volume, number of instruments and tests)
Table 10 U.S. in vitro diagnostics market, by technology, 2017 - 2030 (USD Million) (Volume, number of instruments and tests)
Table 11 U.S. in vitro diagnostics market, by application, 2017 - 2030 (USD Million)
Table 12 U.S. in vitro diagnostics market, by end-use, 2017 - 2030 (USD Million) (Volume, number of instruments and tests)

List of Figures

Fig. 1 U.S. in vitro diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 U.S. in vitro diagnostics market outlook (2021)
Fig. 10 Parent market outlook, 2021
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Taking control of the changing regulatory landscape
Fig. 13 In vitro diagnostic market driver impact
Fig. 14 Geriatric population in the U.S.
Fig. 15 In vitro diagnostics market restraint impact
Fig. 16 Market entry strategy
Fig. 17 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 18 Porter’s five forces analysis
Fig. 19 Strategy mapping
Fig. 20 U.S. in vitro diagnostics market: Product outlook and key takeaways
Fig. 21 U.S. in vitro diagnostics market: Products movement analysis
Fig. 22 Instruments market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 23 Reagents market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 24 Services market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 25 U.S. in vitro diagnostics market: Technology outlook and key takeaways
Fig. 26 U.S. in vitro diagnostics market: Technology movement analysis
Fig. 27 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 28 Instruments market for immunoassay estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 29 Reagents market for immunoassay estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 30 Services market for immunoassay estimates and forecast, 2017 - 2030 (USD Million)
Fig. 31 Hematology market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 32 Instruments market for hematology estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 33 Reagents market for hematology estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 34 Services market for hematology estimates and forecast, 2017 - 2030 (USD Million)
Fig. 35 Clinical chemistry market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 36 Instruments market for clinical chemistry estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 37 Reagents market for clinical chemistry estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 38 Services market for clinical chemistry estimates and forecast, 2017 - 2030 (USD Million)
Fig. 39 Molecular diagnostics market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 40 Instruments market for molecular diagnostics estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 41 Reagents market for molecular diagnostics estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 42 Services market for molecular diagnostics estimates and forecast, 2017 - 2030 (USD Million)
Fig. 43 Coagulation market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 44 Instruments market for coagulation estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 45 Reagents market for coagulation estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 46 Services market for coagulation estimates and forecast, 2017 - 2030 (USD Million)
Fig. 47 Microbiology market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 48 Instruments market for microbiology estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 49 Reagents market for microbiology estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 50 Services market for microbiology estimates and forecast, 2017 - 2030 (USD Million)
Fig. 51 Others market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 52 Instruments others market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 53 Reagents others market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 54 Services market for other technology estimates and forecast, 2017 - 2030 (USD Million)
Fig. 55 U.S. in vitro diagnostics market: End-use outlook and key takeaways
Fig. 56 U.S. in vitro diagnostics market: End-use movement analysis
Fig. 57 Hospitals market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 58 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 59 Instruments market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 60 Reagents market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 61 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 62 Hematology market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 63 Instruments market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 64 Reagents market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 65 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 66 Clinical chemistry market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 67 Instruments market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 68 Reagents market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 69 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 70 Molecular diagnostics market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 71 Instruments market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 72 Reagents market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 73 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 74 Coagulation market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 75 Instruments market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 76 Reagents market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 77 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 78 Microbiology market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 79 Instruments market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 80 Reagents market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 81 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 82 Others market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 83 Instruments market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 84 Reagents market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 85 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 86 Laboratory market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 87 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 88 Instruments market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 89 Reagents market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 90 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 91 Hematology market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 92 Instruments market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 93 Reagents market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 94 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 95 Clinical chemistry market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 96 Instruments market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 97 Reagents market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 98 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 99 Molecular diagnostics market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 100 Instruments market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 101 Reagents market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 102 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 103 Coagulation market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 104 Instruments market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 105 Reagents market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 106 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 107 Microbiology market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 108 Instruments market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 109 Reagents market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 110 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 111 Others market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 112 Instruments market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 113 Reagents market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 114 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 115 Home care market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 116 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 117 Instruments market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 118 Reagents market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 119 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 120 Hematology market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 121 Instruments market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 122 Reagents market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 123 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 124 Clinical chemistry market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 125 Instruments market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 126 Reagents market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 127 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 128 Molecular diagnostics market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 129 Instruments market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 130 Reagents market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 131 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 132 Coagulation market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 133 Instruments market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 134 Reagents market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 135 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 136 Microbiology market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 137 Instruments market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 138 Reagents market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 139 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 140 Others market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 141 Instruments market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of instruments)
Fig. 142 Reagents market estimates and forecast, 2017 - 2030 (USD Million) (volume, number of tests)
Fig. 143 Immunoassay market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 144 Others market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 145 U.S. in vitro diagnostics market: Application outlook and key takeaways
Fig. 146 U.S. in vitro diagnostics market: Application movement analysis
Fig. 147 Infectious diseases market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 148 Upper respiratory market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 149 Gastrointestinal panel testing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 150 MRSA market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 151 Clostridium difficile market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 152 VRE market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 153 Carbapenem-resistant bacteria market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 154 Flu market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 155 RSV market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 156 Candida market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 157 TB and drug-resistant TB market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 158 Meningitis cancer market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 159 Chlamydia market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 160 Gonorrhea market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 161 HIV market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 162 Hepatitis C market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 163 Hepatitis B market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 164 Other infectious disease market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 165 Diabetes market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 166 Oncology market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 167 Cardiology market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 168 Nephrology market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 169 Autoimmune diseases market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 170 Drug testing market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 171 Hematologic diseases market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 172 Others market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 173 U.S. in vitro diagnostics market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 174 Ansoff matrix
Fig. 175 Competition categorization
Fig. 176 Company market share analysis, 2021
Fig. 177 Company market position analysis
Fig. 178 Company profiles
Fig. 179 Regional network map
Fig. 180 Company market position analysis
Fig. 181 Company market position analysis
Fig. 182 Market differentiators
Fig. 183 Company market share analysis, 2021
Fig. 184 Company market position analysis
Fig. 185 Company market position analysis
Fig. 186 Market differentiators
Fig. 187 Company market share analysis, 2021
Fig. 188 Company market position analysis
Fig. 189 Company market position analysis
Fig. 190 Market differentiators
Fig. 191 Company market share analysis, 2021
Fig. 192 Company market position analysis
Fig. 193 Company market position analysis
Fig. 194 Market differentiators
Fig. 195 Company market share analysis, 2021
Fig. 196 Company market position analysis
Fig. 197 Company market position analysis
Fig. 198 Market differentiators
Fig. 199 Strategy mapping
Fig. 200 Company market position analysis
Fig. 201 Company market position analysis
Fig. 202 Market differentiators
Fig. 203 Company market share analysis, 2021
Fig. 204 Strategy mapping
Fig. 205 Company market position analysis
Fig. 206 Company market position analysis
Fig. 207 Market differentiators
Fig. 208 Company market share analysis, 2021